BioCentury
ARTICLE | Company News

Nuvilex cancer, endocrine/metabolic news

September 2, 2013 7:00 AM UTC

Nuvilex restructured and formed three new divisions to focus on its biotechnology core businesses after completing its acquisition of Bio Blue Bird AG from SG Austria Pvt. Ltd. (Singapore). Through it...